Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C

被引:0
作者
Malaponte, G
Passero, E
Leonardi, S
Monte, V
Lauria, C
Mazzarino, C
Sciotto, A
Mancuso, GR
DiGregorio, F
Musumeci, S
机构
[1] CATANIA UNIV, INST GEN PATHOL, CATANIA, ITALY
[2] CATANIA UNIV, DEPT PAEDIAT, CATANIA, ITALY
[3] CATANIA UNIV, DIV PAEDIAT HAEMATOL ONCOL, CATANIA, ITALY
关键词
NK cells; lymphocyte subsets; thalassemia major; hepatitis C; alpha-interferon;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The variation of natural killer (NK) cell activity and lymphocyte subsets 20 h after a single test dose of alpha-IFN, was studied in 17 thalassemic patients with chronic hepatitis C. All patients had suspended the alpha-IFN therapy at least 12 months before the study: 10 were considered responders and 7 nonresponders. Also NK cell cytotoxicity after in vitro incubation with alpha-IFN was studied. The administration of a single dose of alpha-IFN increased NK cell cytotoxic activity significantly in the group of responders and in non-responders; moreover the NK cell cytotoxic activity after alpha-IFN in vitro incubation increased both in responders and nonresponders, but to a lesser degree than in healthy controls. Absolute values of CD4+ and CD8+ lymphocytes decreased significantly only in responders. In conclusion, our data suggest that the variation of NK cytotoxic activity and lymphocyte subsets after a test dose of alpha-IFN can be considered a parameter related to IFN biological effects.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 33 条
  • [1] AKBAR AN, 1987, CLIN EXP IMMUNOL, V70, P345
  • [2] AKBAR AN, 1986, J IMMUNOL, V136, P1635
  • [3] ALTER HJ, 1989, CURRENT PERSPECTIVES, P83
  • [4] BLUMBERG N, 1987, Blood Reviews, V1, P219, DOI 10.1016/0268-960X(87)90023-3
  • [5] BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
  • [6] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [7] EFFECT OF IRON OVERLOAD ON THE RESPONSE TO RECOMBINANT INTERFERON-ALFA TREATMENT IN TRANSFUSION-DEPENDENT PATIENTS WITH THALASSEMIA MAJOR AND CHRONIC HEPATITIS-C
    CLEMENTE, MG
    CONGIA, M
    LAI, ME
    LILLIU, F
    LAMPIS, R
    FRAU, F
    FRAU, MR
    FAA, G
    DIANA, G
    DESSI, C
    MELIS, A
    MAZZOLENI, AP
    CORNACCHIA, G
    CAO, A
    DEVIRGILIIS, S
    [J]. JOURNAL OF PEDIATRICS, 1994, 125 (01) : 123 - 128
  • [8] TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL
    DAVIS, GL
    BALART, LA
    SCHIFF, ER
    LINDSAY, K
    BODENHEIMER, HC
    PERRILLO, RP
    CAREY, W
    JACOBSON, IM
    PAYNE, J
    DIENSTAG, JL
    VANTHIEL, DH
    TAMBURRO, C
    LEFKOWITCH, J
    ALBRECHT, J
    MESCHIEVITZ, C
    ORTEGO, TJ
    GIBAS, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) : 1501 - 1506
  • [9] INTERFERON IN VIRAL-HEPATITIS - ROLE IN PATHOGENESIS AND TREATMENT
    DAVIS, GL
    HOOFNAGLE, JH
    [J]. HEPATOLOGY, 1986, 6 (05) : 1038 - 1041
  • [10] RECOMBINANT ALPHA-INTERFERON TREATMENT OF NON-A, NON-B (TYPE-C) HEPATITIS - REVIEW OF STUDIES AND RECOMMENDATIONS FOR TREATMENT
    DAVIS, GL
    [J]. JOURNAL OF HEPATOLOGY, 1990, 11 : S72 - S77